Activity value 77International Buyer&Supplier,Last transaction date:
2026-02-17
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for manufacturera mundia0l farmaceutica dicegsa s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 600 and a transaction weight of 600.
YearTransactionsQuantityWeight
202578168983.7166583.7
20262600600
Bill of lading data
<
1/15
>
Trade date
2026/02/17
B/L No.
92003005562895
Suppliers
zeillock inc.
Buyers
manufacturera mundia0l farmaceutica dicegsa s.a.
Product description
DO:01260691, PEDIDO 4700062833, DECLARACION 1 DE 1, // FACTURA:20173964, FECHA:08-01-2026 PRODUCTO: MATERIA PRIMA PARA MEDICAMENTO, PANCREATINA 4 NF, COMPOSICION: (AMILASA, LIPASA Y PROTEASA)., ASPECTO FISICO: POLVO AMORFO LIGERAMENTE CAFE, TIPO DE EMPAQUE: TAMBOR DE 5, 10, 20 Y 25 KG, USO: MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOSDE CONSUMO HUMANO, PRODUCTO LEPRITU ENZIMATICO GRAGEAS, MARCA: NO TIENE, REFERENCIA: 104954 , NO. CAS: 8049-47-6, CONCENTRACION O PUREZA DE LA MP: NO APLICA. SE MIDE ENTURMINOS DE ACTIVIDAD ENZIMATICA (LA PANCREATINA CONTIENE, POR CADA MG, NO MENOS DE 25 UNIDADES USP DE ACTIVIDAD DE AMILASA, NO MENOS DE 2,0 UNIDADES USP DE ACTIVIDAD DE LIPASAY NO MENOS DE 25 UNIDADES USP DE ACTIVIDAD DE PROTEASA), CALIDAD FARMACOPEICA DE REFERENCIA: USP, NOMBRE QUIMICO: NO APLICA (SUSTANCIA QUE CONTIENE ENZIMAS, PRINCIPALMENTE AMILASA, LIPASA Y PROTEASA). FÓRMULA MOLECULAR: NO APLICA. LABORATORIO FABRICANTE: KIN MASTER, NO. DE EXPEDIENTE: 20027412, REGISTRO SANITARIO: INVIMA 2022M-0012253-R
Expand
Product description
DO:03253199, PEDIDO 4700062158, DECLARACION 1 DE 1, // FACTURA:470/25-26/1236, FECHA:28-08-2025 PRODUCTO: MATERIA PRIMA PARA MEDICAMENTO, DICLOXACILINA SODICA MONOHIDRATO COMPACTADA, NOMBRE COMERCIAL: DICLOXACILINA SODICA MONOHIDRATO COMPACTADA, NO. CAS (NUMERO DE REGISTRO DEL CHEMICAL ABSTRACTS SERVICE): 13412-64-1, CALIDAD: USP, ASPECTO FISICO: POLVO BLANCO A CASI BLANCO CRISTALINO, CONCENTRACION: DICLOXACILINA SIDICA MONOHIDRATO EQUIVALENTE A MINIMO 850 MICROG DE DICLOXACILINA POR MG. MINIMO 850 MICROGDE DICLOXACILINA (BASE) POR CADA MG DE MATERIA PRIMA., TIPO DE EMPAQUE: TAMBOR DE 25 KG, USO: MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS DE USO HUMANO, PRODUCTO DICLOXACILINA CAPSULAS 500 MG, MARCA: NO TIENE , NOMBRE QUIMICO: (2S,5R,6R)-6-(3-(2,6-DICLOROFENIL)-5-METIL-4-ISOXAZOLCARBOXAMIDO)-3,3-DIMETIL-7-OXO-4-TIA-1-AZABICICLO(3.2.0)HEPTANO-2-CARBOXILATO MONOSIDICO, MONOHIDRATO. FORMULA MOLECULAR: C19H16CL2N3NAO5SIH2O, LABORATORIO FABRICANTE: APITORIA PHARMA PRIVATE LIMITED, PAIS DE ORIGEN: INDIA.NO.
Expand
manufacturera mundia0l farmaceutica dicegsa s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as amoxicillin,ampicillin,penicillins.
According to the 52wmb.com global trade database, as of 2026-02-17, the company has completed 12651 international trades,
with its main trading regions covering colombia,china,united states etc.
The core products include HS2941102000,HS3920490090,HS2941101000 etc,
often transported via buenaventura,port bogota etc,
and its main trading partners are laboratorios la sante c.a.,beta pharmaceuticals ltd.,c.i.farmacapsulas s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on manufacturera mundia0l farmaceutica dicegsa s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.